| Angiokeratoma circumscriptum of the tongue. | |
MedLine Citation:
|
PMID: 21463157 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Angiokeratoma circumscriptum of the tongue is a rare mucocutaneous vascular disorder. To date, only three cases of angiokeratoma circumscriptum of the tongue have been reported in the English literature. In this article, a case with angiokeratoma circumscriptum of the tongue was presented, and all the aspects of this clinical entity including clinical evaluation, differential diagnosis, histopathological features, and treatment modalities were discussed. |
Authors:
|
Görkem Eskiizmir; Gulsum Gencoglan; Peyker Temiz; Aylin Türel Ermertcan |
Related Documents
:
|
23385977 - Sesterterpenoids. 20575867 - Book and media reviews. 21200397 - The good viruses: viral mutualistic symbioses. 23379987 - Linburg-comstock syndrome involving four fingers: a case report and review of the liter... 3901757 - Dialyzer hypersensitivity syndrome: possible role of allergy to ethylene oxide. report ... 23506237 - Femoral vein obturator bypass revascularization in groin infectious bleeding: two case ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-2 |
Journal Detail:
|
Title: Cutaneous and ocular toxicology Volume: - ISSN: 1556-9535 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101266892 Medline TA: Cutan Ocul Toxicol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Otorhinolaryngology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive del...
Next Document: Cancer stem cells: the development of new cancer therapeutics.